日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy
Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…
Innovent Biologics teams with Takeda on global IO therapies
Innovent Biologics and Takeda are teaming up. This global partnership seeks to…
OPTiM AI Hospital Launches Voice Recorder AI Feature
OPTiM Corporation announced on the 21st that it will begin offering new…
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS, an…
UPWARD launches Mobile AI Agent at Medical Japan 2025
UPWARD, a tech startup company based in Tokyo with expertise in AI-powered…
Illumi Medical Completes Series A with 340M Yen Funding
Illumi Medical Inc., which aims to revolutionize medical technology using light, is…
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
A.D.A.M. Partners with SOPHiA for Liquid Biopsy Japan
A.D.A.M. Innovations, Japan’s leading private genetic testing company, has partnered with SOPHiA…
English